Cwestiwn ysgrifenedig WQ85809
- Gofynnwyd gan
- Rhun ap IorwerthPlaid
- I'w ateb gan
- Minister for Health and Social Services
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 5 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
Following NICE's announcement last week regarding Trodelvy, what is the latest with regards to making it available to cancer patients in Wales on the NHS?
Ateb
Atebwyd gan Minister for Health and Social Services
NICE published its final appraisal document recommending the use of Sacituzumab govitecan (Trodelvy®) for treating unresectable triple-negative advanced breast cancer after two or more previous therapies on 14 July. In accordance with the requirements of the New Treatment Fund, health boards must make Trodelvy® routinely available within two months.